Rocket Doctor’s Virtual ED Program Eases Hospital Strain in Canada

The latest announcement is out from Treatment.com International ( (TSE:TRUE) ).

Rocket Doctor, a platform operated by Treatment.com AI Inc., has successfully implemented a virtually-enabled Emergency Department (ED) diversion program in Canada, significantly reducing the strain on overwhelmed hospitals. The program has managed over 3,000 patients virtually at Georgian Bay General Hospital, saving an estimated $1.4 million by diverting patients from the ER. With similar success in Alberta, the platform has facilitated over 12,000 patient visits in three months, with the majority resolved virtually. This initiative addresses the critical need for accessible healthcare alternatives, particularly in rural and remote communities, by empowering physicians with digital tools to provide comprehensive out-patient care.

Spark’s Take on TSE:TRUE Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRUE is a Underperform.

Treatment.com International is struggling financially, with persistent losses and negative cash flow overshadowing recent revenue growth. The stock is technically weak, and valuation metrics highlight its unprofitable status. However, recent corporate events, including strategic acquisitions and partnerships, provide some potential for future growth, although they have not yet addressed the core financial challenges.

To see Spark’s full report on TSE:TRUE stock, click here.

More about Treatment.com International

Treatment.com AI Inc. is a digital health company that operates Rocket Doctor, a platform providing virtual healthcare solutions. The company focuses on leveraging AI-enabled care and smart triage systems to address healthcare challenges, particularly in emergency department settings across Canada.

Average Trading Volume: 130,057

Technical Sentiment Signal: Sell

Current Market Cap: C$28.69M

For an in-depth examination of TRUE stock, go to TipRanks’ Overview page.